SYVC OTC
Synovics Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$26M
+10.6% ▲
5Y CAGR: +281.8%
Gross Profit
$9M
+35.3% ▲
5Y CAGR: +221.4%
Operating Income
-$2M
+75.8% ▲
Net Income
-$4M
+80.8% ▲
EPS (Diluted)
$-0.17
+84.4% ▲
EBITDA
-$2M
+81.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 |
|---|---|---|---|---|---|
| Revenue | $99K | $8K | $11M | $23M | $26M |
| YoY Growth | +208.9% | -91.7% | +128274.0% | +123.1% | +10.6% |
| Cost of Revenue | $18K | $45K | $8M | $17M | $17M |
| Gross Profit | $80K | -$37K | $2M | $7M | $9M |
| Gross Margin | 81.5% | -452.8% | 22.4% | 28.2% | 34.6% |
| R&D Expenses | $0 | $2M | $1M | $1M | $1M |
| SG&A Expenses | $867K | $353K | $5M | $16M | $10M |
| Operating Expenses | $867K | $2M | $6M | $17M | $11M |
| Operating Income | -$786K | -$2M | -$4M | -$10M | -$2M |
| Operating Margin | -796.2% | -23334.5% | -34.4% | -43.7% | -9.6% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$1M | -$3M | -$8M | -$21M | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$3M | -$9M | -$21M | -$4M |
| Net Margin | -1138.4% | -35537.8% | -81.5% | -88.9% | -15.4% |
| EPS (Diluted) | $-0.14 | $-0.14 | $-0.33 | $-1.09 | $-0.17 |
| EBITDA | -$756K | -$2M | -$2M | -$10M | -$2M |
| Shares Outstanding | 8M | 20M | 26M | 19M | 24M |